Hepion Pharmaceuticals, Inc.
HEPA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583771
In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Other share classesCTRVP
13F holders, Q2 2023
Institutional positions in Hepion Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −9 vs. Q1 2023
- Shares held
- 517.1K
- +156.4K (+43.4%) vs. Q1 2023Converted for a 1-for-20 split
- Total value
- $5.43M
- −$173.1K (−3.1%) vs. Q1 2023
- New holders
- 4
- 11 more added
- Sold out
- 13
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HEPA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 4 | $1.39K |
| Q1 2025 | 16 | $419.7K |
| Q4 2024 | 22 | $215.4K |
| Q3 2024 | 22 | $338.2K |
| Q2 2024 | 24 | $863.9K |
| Q1 2024 | 25 | $1.77M |
| Q4 2023 | 24 | $2.42M |
| Q3 2023 | 24 | $4.00M |
| Q2 2023 | 23 | $5.43M |
| Q1 2023 | 32 | $5.60M |
| Q4 2022 | 32 | $2.20M |
| Q3 2022 | 32 | $3.61M |
| Q2 2022 | 34 | $4.24M |
| Q1 2022 | 38 | $9.74M |
| Q4 2021 | 43 | $9.00M |
| Q3 2021 | 42 | $11.9M |
| Q2 2021 | 49 | $21.3M |
| Q1 2021 | 45 | $14.7M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Hepion Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 165,512 | $1.74M | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Octagon Capital Advisors LP | 155,000 | $1.63M | 0.23% | +155,000 | New |
| BlackRock Inc. | 85,752 | $900.4K | 0.00% | +5,613+7.0% | AddedConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 34,875 | $366.2K | 0.00% | +2,052+6.3% | AddedConverted for a 1-for-20 split |
| Morgan Stanley | 23,367 | $245.4K | 0.00% | +18,956+429.8% | AddedConverted for a 1-for-20 split |
| State Street Corp | 15,676 | $164.6K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Susquehanna International Group, LLP | 14,671 | $154.0K | 0.00% | +6,933+89.6% | AddedConverted for a 1-for-20 split |
| Renaissance Technologies LLC | 13,359 | $140.0K | 0.00% | −856−6.0% | ReducedConverted for a 1-for-20 split |
| The PNC Financial Services Group, Inc. | 2,879 | $30.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| UBS Group AG | 2,671 | $28.0K | 0.00% | +1,968+279.7% | AddedConverted for a 1-for-20 split |
| Advisor Group Holdings, Inc. | 2,320 | $24.4K | 0.00% | −56−2.4% | ReducedConverted for a 1-for-20 split |
| Group One Trading, L.P. | 412 | $4.33K | 0.00% | −244−37.2% | ReducedConverted for a 1-for-20 split |
| Tower Research Capital LLC (TRC) | 266 | $2.79K | 0.00% | −262−49.6% | ReducedConverted for a 1-for-20 split |
| Federation des caisses Desjardins du Quebec | 175 | $1.84K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Royal Bank of Canada | 83 | $1.00K | 0.00% | +83 | New |
| Wells Fargo & Company | 27 | $284 | 0.00% | +1+2.3% | AddedConverted for a 1-for-20 split |
| Barclays PLC | 16 | $168 | 0.00% | +1+3.6% | AddedConverted for a 1-for-20 split |
| Signaturefd, LLC | 1 | $11 | 0.00% | +1+900.0% | AddedConverted for a 1-for-20 split |
| Harbor Investment Advisory, LLC | 1 | $11 | 0.00% | +1+1,900.0% | AddedConverted for a 1-for-20 split |
| Allworth Financial LP | 1 | $11 | 0.00% | +1+1,900.0% | AddedConverted for a 1-for-20 split |
| BerganKDV Wealth Management, LLC | 1 | $11 | 0.00% | +1 | New |
| Bank of America Corp | 1 | $10 | 0.00% | +1 | New |
| Benjamin F. Edwards & Company, Inc. | 1 | $0 | 0.00% | +1+1,900.0% | AddedConverted for a 1-for-20 split |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −7,845−100.0% | Sold outConverted for a 1-for-20 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −6,603−100.0% | Sold outConverted for a 1-for-20 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −4,436−100.0% | Sold outConverted for a 1-for-20 split |
| McAdam, LLC | 0 | $0 | 0.00% | −3,108−100.0% | Sold outConverted for a 1-for-20 split |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −3,059−100.0% | Sold outConverted for a 1-for-20 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,675−100.0% | Sold outConverted for a 1-for-20 split |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −1,577−100.0% | Sold outConverted for a 1-for-20 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −1,295−100.0% | Sold outConverted for a 1-for-20 split |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −987−100.0% | Sold outConverted for a 1-for-20 split |
| Amussen Hunsaker Associates LLC | 0 | $0 | 0.00% | −665−100.0% | Sold outConverted for a 1-for-20 split |
| Amplius Wealth Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold outConverted for a 1-for-20 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −82−100.0% | Sold outConverted for a 1-for-20 split |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-20 split |